Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment.

Ramos DM, d'Ydewalle C, Gabbeta V, Dakka A, Klein SK, Norris DA, Matson J, Taylor SJ, Zaworski PG, Prior TW, Snyder PJ, Valdivia D, Hatem CL, Waters I, Gupte N, Swoboda KJ, Rigo F, Bennett CF, Naryshkin N, Paushkin S, Crawford TO, Sumner CJ.

J Clin Invest. 2019 Nov 1;129(11):4817-4831. doi: 10.1172/JCI124120.

2.

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.

Moreau P, Attal M, Hulin C, Arnulf B, Belhadj K, Benboubker L, Béné MC, Broijl A, Caillon H, Caillot D, Corre J, Delforge M, Dejoie T, Doyen C, Facon T, Sonntag C, Fontan J, Garderet L, Jie KS, Karlin L, Kuhnowski F, Lambert J, Leleu X, Lenain P, Macro M, Mathiot C, Orsini-Piocelle F, Perrot A, Stoppa AM, van de Donk NW, Wuilleme S, Zweegman S, Kolb B, Touzeau C, Roussel M, Tiab M, Marolleau JP, Meuleman N, Vekemans MC, Westerman M, Klein SK, Levin MD, Fermand JP, Escoffre-Barbe M, Eveillard JR, Garidi R, Ahmadi T, Zhuang S, Chiu C, Pei L, de Boer C, Smith E, Deraedt W, Kampfenkel T, Schecter J, Vermeulen J, Avet-Loiseau H, Sonneveld P.

Lancet. 2019 Jul 6;394(10192):29-38. doi: 10.1016/S0140-6736(19)31240-1. Epub 2019 Jun 3. Erratum in: Lancet. 2019 Jun 14;:.

PMID:
31171419
3.

Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients.

Franssen LE, Nijhof IS, Bjorklund CC, Chiu H, Doorn R, van Velzen J, Emmelot M, van Kessel B, Levin MD, Bos GMJ, Broijl A, Klein SK, Koene HR, Bloem AC, Beeker A, Faber LM, van der Spek E, Raymakers R, Sonneveld P, Zweegman S, Lokhorst HM, Thakurta A, Qian X, Mutis T, van de Donk NWCJ.

Oncotarget. 2018 Sep 21;9(74):34009-34021. doi: 10.18632/oncotarget.26131. eCollection 2018 Sep 21.

4.

Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial.

van de Donk NW, van der Holt B, Minnema MC, Vellenga E, Croockewit S, Kersten MJ, von dem Borne PA, Ypma P, Schaafsma R, de Weerdt O, Klein SK, Delforge M, Levin MD, Bos GM, Jie KG, Sinnige H, Coenen JL, de Waal EG, Zweegman S, Sonneveld P, Lokhorst HM.

Lancet Haematol. 2018 Oct;5(10):e479-e492. doi: 10.1016/S2352-3026(18)30149-2.

PMID:
30290905
5.

Quality of life and levels of physical activity of residents living in therapeutic residential care facilities in Southern Brazil.

Klein SK, Fofonka A, Hirdes A, Jacob MHVM.

Cien Saude Colet. 2018 May;23(5):1521-1530. doi: 10.1590/1413-81232018235.13432016. Portuguese, English.

6.

Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature.

Timmers NKLM, de Maar JS, van Kruijsdijk RCM, Klein SK.

Ann Hematol. 2018 Sep;97(9):1627-1632. doi: 10.1007/s00277-018-3329-2. Epub 2018 Apr 29. Review.

7.

Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients.

Franssen LE, Nijhof IS, Couto S, Levin MD, Bos GMJ, Broijl A, Klein SK, Ren Y, Wang M, Koene HR, Bloem AC, Beeker A, Faber LM, van der Spek E, Raymakers R, Leguit RJ, Sonneveld P, Zweegman S, Lokhorst H, Mutis T, Thakurta A, Qian X, van de Donk NWCJ.

Haematologica. 2018 Aug;103(8):e368-e371. doi: 10.3324/haematol.2017.186601. Epub 2018 Mar 15. No abstract available.

8.

Automated recording of home cage activity and temperature of individual rats housed in social groups: The Rodent Big Brother project.

Redfern WS, Tse K, Grant C, Keerie A, Simpson DJ, Pedersen JC, Rimmer V, Leslie L, Klein SK, Karp NA, Sillito R, Chartsias A, Lukins T, Heward J, Vickers C, Chapman K, Armstrong JD.

PLoS One. 2017 Sep 6;12(9):e0181068. doi: 10.1371/journal.pone.0181068. eCollection 2017.

9.

Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS.

Ross SJ, Revenko AS, Hanson LL, Ellston R, Staniszewska A, Whalley N, Pandey SK, Revill M, Rooney C, Buckett LK, Klein SK, Hudson K, Monia BP, Zinda M, Blakey DC, Lyne PD, Macleod AR.

Sci Transl Med. 2017 Jun 14;9(394). pii: eaal5253. doi: 10.1126/scitranslmed.aal5253. Erratum in: Sci Transl Med. 2017 Jul 26;9(400):.

PMID:
28615361
10.

Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.

Stevens-Kroef MJ, Olde Weghuis D, ElIdrissi-Zaynoun N, van der Reijden B, Cremers EMP, Alhan C, Westers TM, Visser-Wisselaar HA, Chitu DA, Cunha SM, Vellenga E, Klein SK, Wijermans P, de Greef GE, Schaafsma MR, Muus P, Ossenkoppele GJ, van de Loosdrecht AA, Jansen JH.

Genes Chromosomes Cancer. 2017 Jul;56(7):524-534. doi: 10.1002/gcc.22455. Epub 2017 Mar 31.

PMID:
28236351
11.

Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes.

Cremers EM, Westers TM, Alhan C, Cali C, Visser-Wisselaar HA, Chitu DA, van der Velden VH, Te Marvelde JG, Klein SK, Muus P, Vellenga E, de Greef GE, Legdeur MC, Wijermans PW, Stevens-Kroef MJ, Silva-Coelho PD, Jansen JH, Ossenkoppele GJ, van de Loosdrecht AA; A study on behalf of the HOVON89 study group.

Haematologica. 2017 Feb;102(2):320-326. doi: 10.3324/haematol.2016.147843. Epub 2016 Sep 22.

12.

Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma.

Nijhof IS, Franssen LE, Levin MD, Bos GMJ, Broijl A, Klein SK, Koene HR, Bloem AC, Beeker A, Faber LM, van der Spek E, Ypma PF, Raymakers R, van Spronsen DJ, Westerweel PE, Oostvogels R, van Velzen J, van Kessel B, Mutis T, Sonneveld P, Zweegman S, Lokhorst HM, van de Donk NWCJ.

Blood. 2016 Nov 10;128(19):2297-2306. doi: 10.1182/blood-2016-07-729236. Epub 2016 Sep 19.

PMID:
27647864
13.

Using Automated Image Analysis Algorithms to Distinguish Normal, Aberrant, and Degenerate Mitotic Figures Induced by Eg5 Inhibition.

Bigley AL, Klein SK, Davies B, Williams L, Rudmann DG.

Toxicol Pathol. 2016 Jul;44(5):663-72. doi: 10.1177/0192623316629805. Epub 2016 Mar 2.

PMID:
26936079
14.

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.

Zweegman S, van der Holt B, Mellqvist UH, Salomo M, Bos GM, Levin MD, Visser-Wisselaar H, Hansson M, van der Velden AW, Deenik W, Gruber A, Coenen JL, Plesner T, Klein SK, Tanis BC, Szatkowski DL, Brouwer RE, Westerman M, Leys MR, Sinnige HA, Haukås E, van der Hem KG, Durian MF, Mattijssen EV, van de Donk NW, Stevens-Kroef MJ, Sonneveld P, Waage A.

Blood. 2016 Mar 3;127(9):1109-16. doi: 10.1182/blood-2015-11-679415. Epub 2016 Jan 22.

PMID:
26802176
15.

Cardiovascular safety risk assessment for new candidate drugs from functional and pathological data: Conference report.

Klein SK, Redfern WS.

J Pharmacol Toxicol Methods. 2015 Nov-Dec;76:1-6. doi: 10.1016/j.vascn.2015.06.003. Epub 2015 Jun 28.

PMID:
26126834
16.

Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab.

Nijhof IS, Groen RW, Lokhorst HM, van Kessel B, Bloem AC, van Velzen J, de Jong-Korlaar R, Yuan H, Noort WA, Klein SK, Martens AC, Doshi P, Sasser K, Mutis T, van de Donk NW.

Leukemia. 2015 Oct;29(10):2039-49. doi: 10.1038/leu.2015.123. Epub 2015 May 15.

PMID:
25975191
17.

A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment.

Buijs A, van Wijnen M, van den Blink D, van Gijn M, Klein SK.

Cancer Genet. 2013 Apr;206(4):140-4. doi: 10.1016/j.cancergen.2013.04.001.

PMID:
23751892
18.

Guideline for diagnosis and treatment of Waldenström's macroglobulinaemia.

Vos JM, Minnema MC, Wijermans PW, Croockewit S, Chamuleau ME, Pals ST, Klein SK, Delforge M, van Imhoff GW, Kersten MJ; HOVON Multiple Myeloma Working Party; HOVON Lymphoma Working Party.

Neth J Med. 2013 Mar;71(2):54-62.

19.

Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis.

Herder V, Gerhauser I, Klein SK, Almeida P, Kummerfeld M, Ulrich R, Seehusen F, Rohn K, Schaudien D, Baumgärtner W, Huehn J, Beineke A.

J Neuroimmunol. 2012 Aug 15;249(1-2):27-39. doi: 10.1016/j.jneuroim.2012.04.010. Epub 2012 May 14.

PMID:
22591945
20.

A case report of voriconazole therapy failure in a homozygous ultrarapid CYP2C19*17/*17 patient comedicated with carbamazepine.

Malingré MM, Godschalk PC, Klein SK.

Br J Clin Pharmacol. 2012 Jul;74(1):205-6. doi: 10.1111/j.1365-2125.2011.04156.x. No abstract available.

21.

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study.

Kumar SK, Lee JH, Lahuerta JJ, Morgan G, Richardson PG, Crowley J, Haessler J, Feather J, Hoering A, Moreau P, LeLeu X, Hulin C, Klein SK, Sonneveld P, Siegel D, Bladé J, Goldschmidt H, Jagannath S, Miguel JS, Orlowski R, Palumbo A, Sezer O, Rajkumar SV, Durie BG; International Myeloma Working Group.

Leukemia. 2012 Jan;26(1):149-57. doi: 10.1038/leu.2011.196. Epub 2011 Jul 29. Erratum in: Leukemia. 2012 May;26(5):1153. Nari, Hareth [corrected to Nahi, Hareth].

22.

Nonpharmacological treatment of tics in Tourette syndrome adding videotape training to self-hypnosis.

Lazarus JE, Klein SK.

J Dev Behav Pediatr. 2010 Jul-Aug;31(6):498-504. doi: 10.1097/DBP.0b013e3181e56c5d.

PMID:
20585264
23.

Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA).

Klein SK, Biemond BJ, van Oers MH.

Ann Hematol. 2007 Dec;86(12):917-8. Epub 2007 Jul 10. Review. No abstract available.

24.

[Neoadjuvant chemotherapy of breast carcinomas: what post-therapeutic (preoperative) information is provided by quantitative dynamic MRI?].

Wasser K, Klein SK, Junkermann H, Sinn HP, Darai S, Neff W, Kauczor HU, Delorme S.

Radiologe. 2007 May;47(5):421-9. German.

PMID:
16283153
25.

Is chronic HIV infection associated with venous thrombotic disease? A systematic review.

Klein SK, Slim EJ, de Kruif MD, Keller TT, ten Cate H, van Gorp EC, Brandjes DP.

Neth J Med. 2005 Apr;63(4):129-36. Review.

26.

Infections and endothelial cells.

Keller TT, Mairuhu AT, de Kruif MD, Klein SK, Gerdes VE, ten Cate H, Brandjes DP, Levi M, van Gorp EC.

Cardiovasc Res. 2003 Oct 15;60(1):40-8. Review.

PMID:
14522405
27.

Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy.

Wasser K, Sinn HP, Fink C, Klein SK, Junkermann H, Lüdemann HP, Zuna I, Delorme S.

Eur Radiol. 2003 Jun;13(6):1213-23. Epub 2002 Nov 30.

PMID:
12764635
28.

Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution.

Wasser K, Klein SK, Fink C, Junkermann H, Sinn HP, Zuna I, Knopp MV, Delorme S.

Eur Radiol. 2003 Jan;13(1):80-7. Epub 2002 Sep 5.

PMID:
12541113
29.

Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia.

Schulz H, Klein SK, Rehwald U, Reiser M, Hinke A, Knauf WU, Aulitzky WE, Hensel M, Herold M, Huhn D, Hallek M, Diehl V, Engert A; German CLL Study Group.

Blood. 2002 Nov 1;100(9):3115-20.

PMID:
12384407
30.

[Six-month old girl with an anaphylactic reaction to rice flour, a rare food allergy].

Klein SK, Kremers EM, Vreede WB.

Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1471-3. Dutch.

PMID:
11503318
31.

[Heart malformations and vascular complications associated with Turner's syndrome. Prospective study of 26 patients].

Douchin S, Rossignol AM, Klein SK, Siché JP, Baguet JP, Bost M.

Arch Mal Coeur Vaiss. 2000 May;93(5):565-70. French.

PMID:
10858854
32.
33.

Efficacy of routine fetal ultrasound screening for congenital heart disease in Isère County, France.

Klein SK, Cans C, Robert E, Jouk PS.

Prenat Diagn. 1999 Apr;19(4):318-22.

PMID:
10327135
34.

Influences on first-year recovery from traumatic brain injury in children.

Taylor HG, Yeates KO, Wade SL, Drotar D, Klein SK, Stancin T.

Neuropsychology. 1999 Jan;13(1):76-89.

PMID:
10067779
35.

Cortical localization of human sustained attention: detection with functional MR using a visual vigilance paradigm.

Lewin JS, Friedman L, Wu D, Miller DA, Thompson LA, Klein SK, Wise AL, Hedera P, Buckley P, Meltzer H, Friedland RP, Duerk JL.

J Comput Assist Tomogr. 1996 Sep-Oct;20(5):695-701.

PMID:
8797896
36.

Electrophysiologic manifestations of impaired temporal lobe auditory processing in verbal auditory agnosia.

Klein SK, Kurtzberg D, Brattson A, Kreuzer JA, Stapells DR, Dunn MA, Rapin I, Vaughan HG Jr.

Brain Lang. 1995 Dec;51(3):383-405.

PMID:
8719073
37.

Predictive factors of short-term neurologic outcome in children with encephalitis.

Klein SK, Hom DL, Anderson MR, Latrizza AT, Toltzis P.

Pediatr Neurol. 1994 Nov;11(4):308-12.

PMID:
7702691
38.

Fluent aphasia in children: definition and natural history.

Klein SK, Masur D, Farber K, Shinnar S, Rapin I.

J Child Neurol. 1992 Jan;7(1):50-9.

PMID:
1372626
39.

Evaluation for suspected language disorders in preschool children.

Klein SK.

Pediatr Clin North Am. 1991 Dec;38(6):1455-67. Review.

PMID:
1945551
40.

Clinical assessment of pediatric disorders of higher cerebral function.

Klein SK, Rapin I.

Curr Probl Pediatr. 1990 Jan;20(1):1-60. Review. No abstract available.

PMID:
2178877
41.

Accidental chlorpromazine ingestion as a cause of neuroleptic malignant syndrome in children.

Klein SK, Levinsohn MW, Blumer JL.

J Pediatr. 1985 Dec;107(6):970-3. No abstract available.

PMID:
4067759

Supplemental Content

Loading ...
Support Center